Medicare Enrolled
Dr. Viney Soni, M.D
Pulmonary Disease · Fountain Valley, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Soni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Soni?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Soni
Dr. Viney Soni is a pulmonary disease specialist in Fountain Valley, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Soni performed 12,666 Medicare services across 2,779 unique beneficiaries.
Between the years covered by Open Payments, Dr. Soni received a total of $14,851 from 88 pharmaceutical and/or device companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Soni is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 0% volume in CA
$14,851 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,666
Medicare services
Top 0% in CA for pulmonary disease
2,779
Unique beneficiaries
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~667 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
6,727 | $100 | $215 |
| Nursing facility visit, moderate complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves moderate medical decision making and takes at least 30 minutes. |
1,136 | $90 | $200 |
| Prolonged inpatient or observation care, each additional 15 minutes This code is used for prolonged hospital inpatient or observation care services that extend beyond the total time required for the primary evaluation and management service. It covers each additional 15-minute increment of time spent by the provider. |
1,014 | $26 | $171 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
932 | $145 | $292 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
704 | $99 | $170 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
642 | $177 | $372 |
| Nursing facility visit, high complexity A follow-up visit by a healthcare provider at a nursing facility for an established patient. The visit involves a high level of medical decision making and takes at least 45 minutes. |
435 | $130 | $250 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
222 | $150 | $220 |
| Nursing facility visit, low complexity A daily follow-up visit for an existing patient in a nursing facility involving straightforward medical decision making. The visit requires at least 15 minutes of time if time is used to determine the level of care. |
217 | $63 | $245 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $66 | $112 |
| Home health agency supervision, complex multidisciplinary care Supervision by a physician or allowed practitioner for a patient receiving Medicare-covered services from a participating home health agency. This involves complex and multidisciplinary care modalities, with the patient not present during the supervision. |
143 | $88 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $136 | $250 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
42 | $140 | $150 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
40 | $45 | $95 |
| New patient office visit, complex (60-74 min) | 37 | $188 | $255 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
37 | $37 | $75 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
33 | $27 | $100 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
28 | $10 | $40 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
25 | $178 | $250 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $13 | $60 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
14 | $29 | $30 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
13 | $32 | $40 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
12 | $35 | $150 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$14,851
Total received (2018-2024)
Avg $2,122/year across 7 years
Top 12% in CA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
88
Companies
639
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,851 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,376
2023
$1,870
2022
$2,399
2021
$2,814
2020
$1,382
2019
$1,679
2018
$2,331
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$378
Insmed, Inc.
$272
GlaxoSmithKline, LLC.
$226
Collegium Pharmaceutical, Inc.
$193
Abbott Laboratories
$172
ABBVIE INC.
$142
Actelion Pharmaceuticals US, Inc.
$137
Gilead Sciences, Inc.
$120
Baxter Healthcare
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$63
Radius Health, Inc.
$56
SCILEX PHARMACEUTICALS INC.
$56
Lilly USA, LLC
$52
Amgen Inc.
$45
Electromed, Inc.
$39
Saluda Medical Americas, Inc.
$38
Exact Sciences Corporation
$33
Pulmonx Corporation
$33
Regeneron Healthcare Solutions, Inc.
$33
Medtronic, Inc.
$32
Fresenius Kabi USA, LLC
$30
Mylan Specialty L.P.
$29
PFIZER INC.
$23
BIOTRONIK NRO, Inc.
$20
USWM, LLC
$18
DePuy Synthes Sales Inc.
$16
Top 3 companies account for 36.9% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,485
Abbott Laboratories
$1,333
GlaxoSmithKline, LLC.
$1,028
Amgen Inc.
$819
Janssen Pharmaceuticals, Inc
$717
Insmed, Inc.
$582
Boehringer Ingelheim Pharmaceuticals, Inc.
$561
Grifols USA, LLC
$520
Gilead Sciences, Inc.
$494
Regeneron Healthcare Solutions, Inc.
$473
Novartis Pharmaceuticals Corporation
$349
PFIZER INC.
$346
Philips Electronics North America Corporation
$320
Collegium Pharmaceutical, Inc.
$304
AbbVie Inc.
$298
SANOFI-AVENTIS U.S. LLC
$256
Mylan Specialty L.P.
$252
ABBVIE INC.
$241
Otsuka America Pharmaceutical, Inc.
$234
Medtronic, Inc.
$224
Electromed, Inc.
$216
Inari Medical, Inc.
$210
E.R. Squibb & Sons, L.L.C.
$204
Lilly USA, LLC
$151
Baxter Healthcare
$148
Boston Scientific Corporation
$145
Actelion Pharmaceuticals US, Inc.
$137
Eisai Inc.
$136
Advanced Respiratory, Inc
$134
Allergan, Inc.
$120
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$110
Allergan Inc.
$105
GENZYME CORPORATION
$105
Biohaven Pharmaceutical Holding Company Ltd.
$103
Nevro Corp.
$103
SCILEX PHARMACEUTICALS INC.
$93
Biohaven Pharmaceuticals, Inc.
$92
USWM, LLC
$82
DePuy Synthes Sales Inc.
$66
Genentech USA, Inc.
$59
Jazz Pharmaceuticals Inc.
$58
Sunovion Pharmaceuticals Inc.
$58
PORTOLA PHARMACEUTICALS, INC.
$57
Radius Health, Inc.
$56
Novo Nordisk Inc
$56
Lundbeck LLC
$54
Fresenius Kabi USA, LLC
$54
Pulmonx Corporation
$53
Shire North American Group Inc
$47
Valinor Pharma, LLC
$45
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$45
BOSTON SCIENTIFIC CORPORATION
$42
Amarin Pharma Inc.
$40
Saluda Medical Americas, Inc.
$38
Indivior Inc.
$37
RedHill Biopharma Inc.
$37
Upsher-Smith Laboratories LLC
$37
Hikma Pharmaceuticals USA
$36
BioDelivery Sciences International, Inc.
$35
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$35
Almatica Pharma LLC
$35
Exact Sciences Corporation
$33
Kowa Pharmaceuticals America, Inc.
$33
IDORSIA PHARMACEUTICALS US INC
$32
SI-BONE, Inc.
$30
Merck Sharp & Dohme LLC
$29
Orexo US, Inc.
$24
Sun Pharmaceutical Industries Inc.
$22
SUN PHARMACEUTICAL INDUSTRIES INC.
$22
Scilex Pharmaceuticals Inc.
$21
Assertio Therapeutics, Inc.
$20
ACADIA Pharmaceuticals Inc
$20
Takeda Pharmaceuticals U.S.A., Inc.
$20
BIOTRONIK NRO, Inc.
$20
Biogen, Inc.
$18
ADVANCED RESPIRATORY, INC
$18
Arbor Pharmaceuticals, Inc.
$17
Circassia Pharmaceuticals Inc
$17
Merck Sharp & Dohme Corporation
$17
Pernix Therapeutics Holdings, Inc.
$17
Kaleo, Inc.
$16
Zyla Life Sciences
$15
Inogen, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Iroko Pharmaceuticals, LLC
$13
Vertiflex, Inc.
$13
Daiichi Sankyo Inc.
$12
Avanos Medical
$11
Top 3 companies account for 25.9% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · AIMOVIG · AIRSUPRA · ANORO · ANORO ELLIPTA · APTIOM · Aimovig · Arikayce · BELBUCA · BEVESPI AEROSPHERE · BEVYXXA · BREZTRI · BREZTRI AEROSPHERE · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · BYSTOLIC · Belbuca · Biktarvy · CHANTIX · CHARTIS CATHETER · COOLIEF* COOLED RADIOFREQUENCY · Cambia · Cologuard Collection Kit · Corlanor · DUPIXENT · Dayvigo · Dymista · ELIQUIS · EMGALITY · ETERNA · EVENITY · EVZIO · Edarbi · Evoke · FARXIGA · FASENRA · FLOWTRIEVER CATHETER · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · GILENYA · GLASSIA · GRALISE · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Horizant · INOGEN · INTELLIS · INVOKANA · JANUVIA · JARDIANCE · JYNARQUE · KAPSPARGO · KEYTRUDA · Kloxxado · LEQVIO · LINZESS · LYRICA · Life 2000 Ventilation System · LifeVest · Livalo · Lucemyra · MOUNJARO · MOVANTIK · MULTAQ · Morphabond ER · Movantik · NAPRELAN · NORTHERA · NUCALA · NUPLAZID · NURTEC ODT · OFEV · OPSUMIT · ORTHOVISC · Omnia · Ozempic · PAXLOVID · PRALUENT · PRALUENT ALIROCUMAB INJECTION · PREVNAR 20 · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · Prolastin-C · Prolastin-C Liquid · Prospera · Protege Family of SCS IPGs · Pulmonx Endobronchial Valve EBV · QULIPTA · QUVIVIQ · RELISTOR · REYVOW · RYBELSUS · Repatha · Respiratoriy Care Undiv · S · S&RC Und · S&RC Undivided · SAMSCA · SEEBRI NEOHALER · SHINGRIX · SIGNIA · SMARTVEST · SPECTRA WAVEWRITER · SPINRAZA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUBLOCADE · SYMBICORT · Senza Spinal Cord Stimulation System · Superion ISS · TAGRISSO · TEZSPIRE · TOSYMRA SUMATRIPTAN NASAL SPRAY · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · TUDORZA PRESSAIR · Talicia · The Monarch Airway Clearance System · The Vest System Model 105 Home Care · The VitalCough System · Trilogy 100 · Tymlos · UBRELVY · VIBERZI · VIVLODEX · VRAYLAR · Vascepa · Veklury · XARELTO · XOLAIR · XTAMPZA · Xolair · YUPELRI · Yupelri · ZENPEP · ZOHYDRO ER · ZORVOLEX · ZTLido · Zubsolv · iFuse Implant · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
147
Per 100K population
4.6
County median income
$113,702
Nearest hospital
UCI HEALTH - FOUNTAIN VALLEY
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Soni is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 12% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Soni experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Soni performed 6,727 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Soni receive payments from pharmaceutical companies?
Yes. Dr. Soni received a total of $14,851 from 88 companies across 639 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Soni's costs compare to other pulmonary diseases in Fountain Valley?
Dr. Soni's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Soni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Fountain Valley
Browse pulmonary diseases in Fountain Valley ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in CA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in CA
Which CA pulmonary diseases receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology